SMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 695-699

  Hu, Yanliang ^a   Sun, Zhifang ^a   Zhang, Anhua ^a   Zhang, Jinjie ^a  

^a Gaomi People's Hospital   (China)

Author keywords

Association; Colorectal cancer; Meta analysis; Polymorphism; SMAD7

Indexed keywords

SMAD7 PROTEIN;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; COCHRANE LIBRARY; COLORECTAL CANCER; EMBASE; GENE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MEDLINE; PRIORITY JOURNAL; PUBLISHING; QUANTITATIVE ANALYSIS; RACE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMAD7 GENE;

ALLELES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK; SMAD7 PROTEIN;

EID: 84894468128     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1095-2     Document Type: Article

References (30)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
2. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765-81.
3. Sung JJ, Lau JY, Goh KL, Leung WK. Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871-6.
4. Zhao P, Dai M, Chen W, et al. Cancer trends in China. Jpn J Clin Oncol. 2010;40:281-5.
5. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78-85.
6. Sameer AS. Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir. Tumor Biol. 2013;34:1301-15.
7. Massague J. TGF-beta in cancer. Cell. 2008;134:215-30.
8. Hong S, Lim S, Li AG, Lee C, Lee YS, Lee EK, et al. Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol. 2007;8:504-13.
9. Ho JW, Choi SC, Lee YF, Hui TC, Cherny SS, Garcia-Barceló MM, et al. Replication study of SNP associations for colorectal cancer in Hong Kong Chinese. Br J Cancer. 2011;104:369-75.
10. Li X, Yang XX, Hu NY, Sun JZ, Li FX, Li M. A risk-associated single nucleotide polymorphism of SMAD7 is common to colorectal, gastric, and lung cancers in a Han Chinese population. Mol Biol Rep. 2011;38:5093-7.
11. Slattery ML, Herrick J, Curtin K, Samowitz W, Wolff RK, Caan BJ, et al. Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. Cancer Res. 2010;70:2996-7.
12. Thompson CL, Plummer SJ, Acheson LS, Tucker TC, Casey G, Li L. Association of common genetic variants in SMAD7 and risk of colon cancer. Carcinogenesis. 2009;30:982-6.
13. Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, et al. Colorectal Cancer Study Group. Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol Biomarkers Prev. 2009;18:616-21.
14. Broderick P, Carvajal-Carmona L, PittmanAM,Webb E, Howarth K, Rowan A, et al. CORGI Consortium, Kerr D, Gray R, Peto J, Cazier JB, Tomlinson I, Houlston RS. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet. 2007;39:1315-7.
15. Mantel N, HaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
16. DerSimonian R, LairdN.Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
17. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516-7.
18. Zhang H, Xu Y, Zhang Z, Liu R,Ma B. Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis. BMC Immunol. 2012;13:14.
19. Zhang H, Ma H, Xu Y, Li L. Association of SMAD7 rs12953717 polymorphism with cancer: a meta-analysis. PLoS One. 2013;8:e58170.
20. ZhangH,Wang A, MaH, XuY. Association between insulin receptor substrate 1 Gly972Arg polymorphism and cancer risk. Tumor Biol. 2013. doi:10.1007/s13277- 013-0855-3.
21. Zhang H, Xu Y, Zhang Z, Li L. The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls. BMC Cancer. 2011;11:391.
22. Zhang H, Xu Y, Li L, Liu R, Ma B. The interleukin-6-174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis. Urol Int. 2012;88:447-53.
23. Zhang H, Li L, Xu Y. CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis. PLoS One. 2013;8:e68634.
24. Jiang O, Zhou R,Wu D, Liu Y,WuW, Cheng N. CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis. Tumor Biol. 2013;34:1215-24.
25. Zeng FR, Ling Y, Yang J, Tian XC, Yang X, Luo RC. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer: a meta-analysis. Tumor Biol. 2013;34:555-63.
26. Malhotra P, Anwar M, Nanda N, Kochhar R, Wig JD, Vaiphei K, et al. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians. Tumor Biol. 2013;34:1901-11.
27. Zhao L, Li K, Li W, Yang Z. Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects. Tumor Biol. 2013;34:1949-57.
28. Wikberg ML, Edin S, Lundberg IV, Van Guelpen B, Dahlin AM, Rutegård J, et al.High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis. Tumor Biol. 2013;34:1013-20.
29. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004;20:439-44.
30. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37:120-32.